Variable | Baseline | Week 2 | Week 4 | Week 6 |
Acetylcholine (nmol/L) |
|
|
|
|
Placebo | 2.45 ± 0.20 | 2.44 ± 0.21 | 2.39 ± 0.18 | 2.43 ± 0.19 |
Supplement | 2.20 ± 0.15 | 2.42 ± 0.12 | 2.29 ± 0.06 | 2.49 ± 0.18 |
BDNF (ng/mL) |
|
|
|
|
Placebo | 36.5 ± 4.2 | 37.3 ± 5.0 | 37.6 ± 3.4 | 38.0 ± 3.7 |
Supplement | 34.7 ± 4.0 | 36.4 ± 4.9 | 32.1 ± 3.4 | 41.1 ± 2.8 ** |
irisin (ng/mL) |
|
|
|
|
Placebo | 29.9 ± 0.6 | 30.0 ± 0.9 | 29.6 ± 1.2 | 29.7 ± 1.1 |
Supplement | 29.6 ± 0.6 | 30.1 ± 0.7 | 29.0 ± 0.4 | 30.8 ± 0.5** |
Melatonin (pg/mL) |
|
|
|
|
Placebo | 1029.1 ± 13.1 | 1033.5 ± 5.7 | 1036.2 ± 8.5 | 1032.2 ± 15.9 |
Supplement | 1051.7 ± 7.0 | 1049.5 ± 3.7 | 1036.5 ± 8.9 | 1057.3 ± 2.4** |